Chiltern Announces The Promotion Of Alecia Barbee To VP, Global Biometrics

LONDON and WILMINGTON, N.C., May 30, 2013 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announces the promotion of Alecia Barbee to the position of Vice President, Global Biometrics.

Dr Jim Esinhart, CEO of Chiltern stated: "We are extremely pleased to announce the promotion of Alecia Barbee from Executive Director of Biometrics to VP of Global Biometrics. In this role, Alecia will have global oversight of data management, data programming, biostatistics and e-clinical functions in Chiltern to provide the best-in-class and comprehensive biometrics solutions to our global client base." 

Alecia Barbee has more than 20 years of CRO experience and joined Chiltern in 2006. Prior to her promotion, Alecia was responsible for oversight of all Biometrics activities in the US.  Alecia is a member of the Drug Information Association and the Society for Clinical Data Management. Alecia is based in Wilmington, NC.

Aize Smink, Chief Operating Officer of Chiltern added: "With Alecia's long, highly successful track record within Chiltern and previously with other major CROs, I am proud to have Alecia represent Biometrics on our global operations management team. With her dedication and hands on approach, we will continue to differentiate Chiltern as a solid mid-sized alternative for our clients who prefer a more tailored approach to their strategic objectives."

Chiltern's innovative approach on more than 200 Electronic Data Capture (EDC) studies in the last 5 years is continually exceeding our sponsors' expectations. The depth of our expertise gives Chiltern the ability to customize and deliver on the particular needs of our clients. We have also expanded our experience in Clinical Data Interchange Standards Consortium (CDISC) standards and provide our sponsors with fully compliant submission ready Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) deliverables.

Company profile

About Chiltern:
Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs more than 1,500 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.

SOURCE Chiltern